» Articles » PMID: 20078222

Mitochondrial Energetics and Therapeutics

Overview
Journal Annu Rev Pathol
Publisher Annual Reviews
Specialty Pathology
Date 2010 Jan 19
PMID 20078222
Citations 318
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction has been linked to a wide range of degenerative and metabolic diseases, cancer, and aging. All these clinical manifestations arise from the central role of bioenergetics in cell biology. Although genetic therapies are maturing as the rules of bioenergetic genetics are clarified, metabolic therapies have been ineffectual. This failure results from our limited appreciation of the role of bioenergetics as the interface between the environment and the cell. A systems approach, which, ironically, was first successfully applied over 80 years ago with the introduction of the ketogenic diet, is required. Analysis of the many ways that a shift from carbohydrate glycolytic metabolism to fatty acid and ketone oxidative metabolism may modulate metabolism, signal transduction pathways, and the epigenome gives us an appreciation of the ketogenic diet and the potential for bioenergetic therapeutics.

Citing Articles

Role of Mitochondrial Dynamics in Skin Homeostasis: An Update.

Quan T, Li R, Gao T Int J Mol Sci. 2025; 26(5).

PMID: 40076431 PMC: 11898645. DOI: 10.3390/ijms26051803.


Assisted Reproduction Technologies (ART): Impact of Mitochondrial (Dys)function and Antioxidant Therapy.

Ferreira F, Teixeira J, Lidon F, Cagide F, Borges F, Pereira R Animals (Basel). 2025; 15(3).

PMID: 39943058 PMC: 11815877. DOI: 10.3390/ani15030289.


Hypoxia signature derived from tumor-associated endothelial cells predict prognosis in gastric cancer.

Wang R, Liu G, Wang K, Pan Z, Pei Z, Hu X Front Cell Dev Biol. 2025; 13:1515681.

PMID: 39901877 PMC: 11788339. DOI: 10.3389/fcell.2025.1515681.


Mitochondrial disease and epilepsy in children.

Zhang X, Zhang B, Tao Z, Liang J Front Neurol. 2025; 15():1499876.

PMID: 39850733 PMC: 11754068. DOI: 10.3389/fneur.2024.1499876.


Organelle-Targeting Nanoparticles.

Soukar J, Peppas N, Gaharwar A Adv Sci (Weinh). 2025; 12(7):e2411720.

PMID: 39806939 PMC: 11831507. DOI: 10.1002/advs.202411720.


References
1.
Rustin P, von Kleist-Retzow J, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A . Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet. 1999; 354(9177):477-9. DOI: 10.1016/S0140-6736(99)01341-0. View

2.
Schriner S, Linford N, Martin G, Treuting P, Ogburn C, Emond M . Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005; 308(5730):1909-11. DOI: 10.1126/science.1106653. View

3.
Manfredi G, Fu J, Ojaimi J, Sadlock J, Kwong J, Guy J . Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet. 2002; 30(4):394-9. DOI: 10.1038/ng851. View

4.
Ruiz-Pesini E, Wallace D . Evidence for adaptive selection acting on the tRNA and rRNA genes of human mitochondrial DNA. Hum Mutat. 2006; 27(11):1072-81. DOI: 10.1002/humu.20378. View

5.
Milne J, Lambert P, Schenk S, Carney D, Smith J, Gagne D . Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450(7170):712-6. PMC: 2753457. DOI: 10.1038/nature06261. View